Byotrol Plc
("Byotrol" or the "Company")
Director Dealing
Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that, on 2nd April 2024, David Traynor, Interim CEO of the Company, purchased a total of 2,808,326 ordinary shares of 0.25p each ("Ordinary Shares") at an average price of 0.134p per Ordinary Share (the "Purchase").
Following the Purchase, Mr. Traynor's beneficial holding is 12,743,623 Ordinary Shares, representing 2.8% of the total voting rights of the Company. As announced on 28 July 2022, Mr. Traynor subscribed for convertible loan notes in the Company, which if converted would represent an additional 0.34% of the total voting rights of the Company.
For further information contact:
| Byotrol Plc | |
| Dr Trevor Francis, Non- Executive Chairman | +44 (0)1925 742 000 |
| David Traynor, Interim Chief Executive Officer Chris Sedwell, Chief Financial Officer
| |
| | |
| Cavendish Capital Markets Limited (Nominated Adviser and Broker) | +44 (0)20 7220 0500 |
| Geoff Nash/George Dollemore - Corporate Finance Nigel Birks/Harriet Ward - ECM | |
| | |
| | |
| Flagstaff Strategic and Investor Communications | +44 (0)20 7129 1474 |
| Tim Thompson/Andrea Seymour/Fergus Mellon
|
|
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
Notes to editors
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the animal and human healthare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.
Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.
For more information, go to byotrol.com
The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | David Traynor | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Interim Chief Executive Officer | ||||
| b) | Initial notification/Amendment | Initial Notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Byotrol plc | ||||
| b) | LEI | 213800AJMTSTIPA59A34 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.25 pence per share | ||||
| Identification code | GB00B0999995 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: ·Aggregated volume · Price |
See 4c) above | ||||
| e) | Date of the transaction | 2 April 2024 | ||||
| f) | Place of the transaction | AIM, London Stock Exchange (XLON) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.